BiotechTubeBiotechTube
Home/MiNK Therapeutics/Jennifer Buell, Ph.D.
JB

Jennifer Buell, Ph.D.

Chief Executive Officer

MiNK Therapeutics

Therapeutic Areas

OncologyPulmonary DiseasesImmunology

MiNK Therapeutics Pipeline

DrugIndicationPhase
agenT-797Solid TumorsPhase 1/2
Engineered iNKT Cell Programs (e.g., CAR-iNKT)Precision Oncology TargetsPreclinical

Leadership Team at MiNK Therapeutics

DN
Dr. Nils Rudqvist
Senior Director, Research
SC
Sandra Craig
Executive Director of Manufacturing
RS
Robert Stein, M.D., Ph.D.
Scientific Advisor
MH
Manuel Hidalgo, M.D., Ph.D.
Scientific Advisor
ME
Mark Exley, Ph.D.
Scientific Advisor
JG
Jenny Gumperz, Ph.D.
Scientific Advisor
View full MiNK Therapeutics profile